Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
69.39 USD | +3.54% | +1.31% | +12.57% |
Oct. 26 | Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating | MT |
Sep. 26 | Healthequity Insider Sold Shares Worth $143,704, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 989 M | Sales 2025 * | 1,129 M | Capitalization | 5,942 M |
---|---|---|---|---|---|
Net income 2024 * | 22.00 M | Net income 2025 * | 73.00 M | EV / Sales 2024 * | 6,57x |
Net Debt 2024 * | 558 M | Net Debt 2025 * | 324 M | EV / Sales 2025 * | 5,55x |
P/E ratio 2024 * | 253x | P/E ratio 2025 * | 66,4x | Employees | 3,189 |
Yield 2024 * | - | Yield 2025 * | - | Free-Float | 97.98% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +3.54% | ||
1 week | +1.31% | ||
Current month | +3.54% | ||
1 month | +1.89% | ||
3 months | +4.47% | ||
6 months | +24.73% | ||
Current year | +12.57% |
1 week
65.56
69.60

1 month
61.81
70.50

Current year
48.86
76.62

1 year
48.86
76.62

3 years
36.81
93.32

5 years
34.40
93.32

10 years
15.80
101.58

Managers | Title | Age | Since |
---|---|---|---|
Stephen Neeleman
FOU | Founder | 55 | 2002 |
Jon Kessler
CEO | Chief Executive Officer | 55 | 2009 |
Elimelech Rosner
CTO | Chief Tech/Sci/R&D Officer | 66 | 2022 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Black
BRD | Director/Board Member | 65 | 2022 |
Robert Selander
CHM | Chairman | 72 | 2015 |
Adrian Dillon
BRD | Director/Board Member | 69 | 2016 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.28% | 323 M€ | -7.64% | - | |
4.41% | 11 M€ | +6.40% | ||
2.11% | 158 M€ | +21.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 69.39 | +3.54% | 862,605 |
23-11-30 | 67.02 | +1.59% | 865,395 |
23-11-29 | 65.97 | -1.32% | 616,837 |
23-11-28 | 66.85 | -0.40% | 516,903 |
23-11-27 | 67.12 | -2.00% | 504,404 |
Delayed Quote Nasdaq, December 01, 2023 at 04:00 pm EST
More quotes
HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.
Sector
Software
Calendar
2023-12-04
- Q3 2024 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
BUY
Number of Analysts
12
Last Close Price
69.39USD
Average target price
85.83USD
Spread / Average Target
+23.70%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.57% | 5 942 M $ | |
+56.16% | 2783 B $ | |
+68.30% | 73 552 M $ | |
+29.29% | 61 811 M $ | |
+51.62% | 50 350 M $ | |
+215.73% | 44 107 M $ | |
+59.71% | 35 105 M $ | |
+51.58% | 26 843 M $ | |
+75.78% | 25 499 M $ | |
+42.13% | 25 230 M $ |